SavedAdd your journal

Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2011 / Cilt: 12 - Sayı: 2

Benign ve malign neoplastik deri lezyonlarında epidermal langerhans hücreleri ve dermal mast hücreleri

Epidermal langerhans cells and dermal mast cells in bening and malignant neoplastic skin lesions

Canten TATAROĞLU
Nil ÇULHACI
Emel DİKİCİOĞLU ÇETİN
Zehra KESEN
Hicran TURHAN
Pages
11–16
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Both epidermal Langerhans cells and dermal mast cells which have some contributions in the immune system, are different in number in benign and malignant skin tumors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PORPOSE: Langerhans cells and mast cells are bone marrow derived cells.
📊
Key Findings & Data:In the present study, we aimed to evaluate the role of mast cells and Langerhans cells in benign and malignant squamous tumors.MATERIALS and METHODS: This study included 12 patients with seborrheic keratosis, 9 patients with actinic keratosis, 15 patients with keratoacanthoma and 33 patients with squamous cell carcinoma.
💡
Conclusion & Impact:Both epidermal Langerhans cells and dermal mast cells which have some contributions in the immune system, are different in number in benign and malignant skin tumors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PORPOSE: Langerhans cells and mast cells are bone marrow derived cells. They represent a critical role in the immune system in the epidermis and dermis. In the present study, we aimed to evaluate the role of mast cells and Langerhans cells in benign and malignant squamous tumors.MATERIALS and METHODS: This study included 12 patients with seborrheic keratosis, 9 patients with actinic keratosis, 15 patients with keratoacanthoma and 33 patients with squamous cell carcinoma. Dermal mast cells and epidermal peri and intratumoral Langerhans cells were labeled with mast cell tryptase and CD1a antibodies respectively.RESULTS: The number of mast cells were significantly increased in the patients with squamous cell carcinoma in comparison with seborrheic keratosis (p=0.001). However, this parameter did not show significant difference between patients of other groups. The number of intratumoral Langerhans cells in seborrheic keratosis were significantly increased in comparison with squamous cell carcinoma (p=0.026). The peritumoral Langerhans cells were increased in squamous cell carcinoma (p=0.007, p=0.001) and keratoacanthoma (p=0.001, p=0.001) in comparison with actinic keratosis and seborrheic keratosis.CONCLUSION: Our immunohistochemical study has demonstrated that peritumoral Langerhans cells and mast cells are increased in number in keratoacanthoma and squamous cell carcinoma. Both epidermal Langerhans cells and dermal mast cells which have some contributions in the immune system, are different in number in benign and malignant skin tumors.

Özet

AMAÇ: Langerhans hücreleri ve mast hücreleri kemik iliği kökenli hücreler olup dermis ve epidermisin immun sisteminde kritik rol oynarlar. Biz bu çalışmada benign ve malign skuamoid tümörlerde mast hücre ve Langerhans hücrelerinin rolünü değerlendirmeyi amaçladık.GEREÇ ve YÖNTEM: Bu araştırmaya 12 seboreik keratoz, 9 aktinik keratoz, 15 keratoakantom ve 33 skuamöz hücreli karsinom olgusu alındı. Dermal mast hücreleri ve epidermal peri ve intratümöral Langerhans hücreleri sırasıyla mast hücre triptaz ve CD1a antikorlarıyla boyandı.BULGULAR: Mast hücre sayısı skuamöz hücreli karsinomda seboreik keratoza göre anlamlı olarak yüksekti (p=0.001). Mast hücre sayısı diğer tümör grupları arasında farklılık göstermedi. İntratümöral Langerhans hücreleri seboreik keratozda skuamöz hücreli karsinoma göre önemli oranda artmış saptandı (p=0.026). Peritümöral Langerhans hücreleri ise skuamöz hücreli karsinom (p=0.007, p=0.001) ve keratoakantomda (p=0.001, p=0.001), aktinik keratoz ve seboreik keratoza oranla artmış olarak saptandı.SONUÇ: Sonuç olarak biz çalışmamızda skuamöz hücreli karsinom ve keratoakantomda peritümöral Langerhans hücreleri ve mast hücrelerini sayıca artmış bulduk. İmmün sistemde görevleri bulunan epidermal Langerhans hücreleri ve dermal mast hücrelerinin benign ve malign deri tümörlerinde farklı rolleri olduğunu düşündürmektedir.

🔖

Cite This Article

TATAROĞLU, C., ÇULHACI, N., ÇETİN, E. D., KESEN, Z., TURHAN, H. (2022). Benign ve malign neoplastik deri lezyonlarında epidermal langerhans hücreleri ve dermal mast hücreleri. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 12 - Sayı: 2, 11–16. https://ajindex.com/articles/428898

References (15)

  1. Koch S, Kohl K, Klein E, Bubnoff D, Bieber T. Skin homing of langerhans cell precursors: adhesion, chemotaxis, and migration. J Allergy Clin Immunol 2006;17:163-8
  2. Melo MR, Filho JLA, Patu VJR, Machado MCF, Mello LA, Carvalho LB. Langerhans cells in cutaneous tumors: immunohistochemistry study using a computer image analysis system. J Mol Histol 2006;37:321-5
  3. Rotsztejn H, Budzko ET, Kupnicka DJ. Langerhans cell in vulvar lichen sclerosus and vulvar squamous cell carcinoma. Arch Immunol Ther Exp 2006;54:363-6
  4. Holikova Z, Hercokova J, Plzak J, Smetana K. Dendritic cells and their role in skin induced immune responses. JEADV 2001;15:116-20
  5. Fieber C, Baumann P, Vallon R, Termeer C, Simon JC, Hofmann M, Angel P, Herrlich P, Sleeman JP. Hyaluronan oligosaccharide induced transcription of metalloproteases. J Cell Science 2003;117:359-67
  6. Valladeau J, Saeland S. Cutaneous dendritic cells. Sem Immunol 2005;17:273-83
  7. Grimbaldeston MA, Finlay-Jones JJ, Hart PH. Mast cells in photodamaged skin: what is their role in skin cancer? Photochem Photobiol Sci 2006;5:177-83
  8. Grimbaldeston MA, Skov L, Finlay-Jones JJ, Hart PH. Squamous cell carcinoma is not associated with high dermal mast cell prevalence in humans. J Invest Dermatol 2002;119:1204-6
  9. Ching S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignanacies. Mod Pathol 2006;19:149-59
  10. Woods GM, Malley RC, Muller HK. The skin immune system and the challenge of tumour immunosurveillance. Eur J Dermatol 2005;15:63-9
  11. McArdle JP, Knight BA, Halliday GM, Muller HK, Rowden G. Quantitative assesment of langerhans cells in actinic keratosis, bowens disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma. Pathology 1986;18:212-6
  12. Berhane T, Halliday GM, Cooke B, Barnetson RSC. Inflammation is associated with progression of actinic keratosis to squmous cell carcinoma. Br J Dermatol 2002;146:810-5
  13. Takahara M, Chen S, Kido M, Takeuchi S, Uchi H, Tu Y, Moroi Y, Furue M. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes. J Cutan Pathol 2009;36:668-74
  14. Rotsztejn H, Budzko ET, Kupnicka DJ. Do Langerhans cells play a role in vulvar epithelium resistance to squamous cell carcinoma? Arch Immunol Ther Exp 2007;55:127-30
  15. Cribier B, Asch PH, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological cr